Commonwealth Equity Services, LLC Abb Vie Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 1,224,083 shares of ABBV stock, worth $220 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

1,224,083

Previous 1,234,379 0.83%

Holding current value

$220 Million

Previous $212 Million 14.17%

% of portfolio

0.37%

Previous 0.34%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$163.84 - $199.33 $1.69 Million - $2.05 Million	-10,296 Reduced 0.83%	1,224,083 $242 Million
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $3.04 Million - $3.55 Million	19,662 Added 1.62%	1,234,379 $212 Million
Q1 2024 Apr 29, 2024	BUY	$159.82 - $182.1 $3.21 Million - $3.65 Million	20,070 Added 1.68%	1,214,717 $221 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $2.52 Million - $2.83 Million	-18,290 Reduced 1.51%	1,194,647 $185 Million
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $1.21 Million - $1.4 Million	-9,040 Reduced 0.74%	1,212,937 $181 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $5.52 Million - $6.87 Million	-41,680 Reduced 3.3%	1,221,977 $165 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $2.36 Million - $2.72 Million	-16,342 Reduced 1.28%	1,263,657 $201 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $637,332 - $764,328	4,608 Added 0.36%	1,279,999 $207 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2.74 Million - $3.15 Million	-20,447 Reduced 1.58%	1,275,391 $171 Million
Q2 2022 Jul 19, 2022	BUY	$137.62 - $174.96 $173,401 - $220,449	1,260 Added 0.1%	1,295,838 $198 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $841,636 - $1.04 Million	6,377 Added 0.5%	1,294,578 $210 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $7.29 Million - $9.22 Million	67,815 Added 5.56%	1,288,201 $174 Million
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $4.49 Million - $5.09 Million	42,153 Added 3.58%	1,220,386 $132 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $2.3 Million - $2.57 Million	21,907 Added 1.89%	1,178,233 $133 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $3.1 Million - $3.41 Million	30,317 Added 2.69%	1,156,326 $125 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $7.15 Million - $9.65 Million	88,816 Added 8.56%	1,126,009 $121 Million
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $3.58 Million - $4.2 Million	41,664 Added 4.19%	1,037,193 $90.8 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $8.87 Million - $11.9 Million	120,912 Added 13.82%	995,529 $97.7 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $2.67 Million - $4.04 Million	41,338 Added 4.96%	874,617 $66.6 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $1.42 Million - $1.78 Million	19,715 Added 2.42%	833,279 $73.8 Million
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $5.16 Million - $6.21 Million	-82,010 Reduced 9.16%	813,564 $61.6 Million
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $1 Million - $1.28 Million	15,287 Added 1.74%	895,574 $65.1 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $2.66 Million - $3.14 Million	34,533 Added 4.08%	880,287 $70.9 Million
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $4.55 Million - $5.61 Million	58,391 Added 7.42%	845,754 $78 Million
Q3 2018 Nov 06, 2018	BUY	$88.91 - $98.84 $199,602 - $221,895	2,245 Added 0.29%	787,363 $74.5 Million
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $2.63 Million - $3.12 Million	29,343 Added 3.88%	785,118 $72.7 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $1.48 Million - $1.99 Million	16,120 Added 2.18%	755,775 $71.5 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $66.2 Million - $72.6 Million	739,655	739,655 $71.5 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Abb Vie Inc. Transaction History